comparemela.com

Latest Breaking News On - Helen bellwood - Page 1 : comparemela.com

Khiron Life Sciences Corp : Khiron Life Sciences Reports Third Quarter 2022 Financial Results

In Europe, revenues increased by 141% year-over-year, driven by revenues in the United Kingdom, where the Corporation is now increasing its existing product portfolio, and the specialized cannabis

Rio de janeiroEstado do rioUnited statesUnited kingdomAlvaro madiedoFranziska katterbachKhiron europePharmadrug gmbhAlvaro torresHelen bellwoodJuan diegoVp corporate affairsInternational financial reporting standardsCorporation third quarterPrnewswire khiron life sciences corpKhiron life sciences corp

Khiron Life Sciences Reports Third Quarter 2022 Financial Results

In Europe, revenues increased by 141% year-over-year, driven by revenues in the United Kingdom, where the Corporation is now increasing its existi.

Rio de janeiroEstado do rioUnited statesUnited kingdomFranziska katterbachKhiron europePharmadrug gmbhAlvaro torresHelen bellwoodJuan diegoVp corporate affairsGroup khiron life sciences corpInternational financial reporting standardsCorporation third quarterKhiron life sciences corpClinics united kingdom

Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022

/PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMXC), the global leader in medical cannabis.

United statesUnited kingdomFranziska katterbachKhiron europeAlvaro torresHelen bellwoodCompany third quarterRegulation services providerKhiron life sciences corpLife sciencesLatin americaConference callThird quarterKhiron chief executive officerKhiron chief financial officerChief executive officer

Khiron Life Sciences Reports Second Quarter 2022 Financial Results

Reports revenues of $9.1 million in the first half of 2022, up 62% year-over-year, reflecting continued medical cannabis momentum in target market.

Rio de janeiroEstado do rioUnited statesUnited kingdomJuan diego alvarezKhiron europeAlvaro yaJimena ochoaRodrigo duranPharmadrug gmbFranziska katterbachAngela acostaPharmdrug gmbAlvaro torresVicente foxHelen bellwood

Khiron to Host Second Quarter 2022 Conference Call on August 29, 2022

/PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)(Frankfurt: A2JMXC), the global leader in medical cannabis.

United statesUnited kingdomFranziska katterbachKhiron europeAlvaro torresHelen bellwoodRegulation services providerCompany second quarterKhiron life sciences corpLife sciencesLatin americaConference callSecond quarterKhiron chief executive officerKhiron chief financial officerChief executive officer

vimarsana © 2020. All Rights Reserved.